LONDON BROKER RATINGS: UBS cuts Diageo; Goldman Sachs cuts NatWest
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More
| Price | 320.50p on 15-01-2026 at 08:30:16 |
|---|---|
| Change | 0.50p 0.16% |
| Buy | 321.00p |
| Sell | 319.50p |
| Last Trade: | Buy 139.00 at 320.50p |
| Day's Volume: | 5,967 |
| Last Close: | 320.00p |
| Open: | 325.50p |
| ISIN: | GB00BKRC5K31 |
| Day's Range | 319.50p - 325.50p |
| 52wk Range: | 293.00p - 423.00p |
| Market Capitalisation: | £802.13m |
| VWAP: | 320.88875p |
| Shares in Issue: | 250.28m |
Genuit Group (GEN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 139 | 320.50p | Automatic Execution |
08:29:01 - 15-Jan-26 |
| Buy* | 150 | 320.50p | Automatic Execution |
08:29:01 - 15-Jan-26 |
| Buy* | 100 | 320.50p | Automatic Execution |
08:29:01 - 15-Jan-26 |
| Sell* | 665 | 319.50p | Automatic Execution |
08:26:05 - 15-Jan-26 |
| Sell* | 253 | 319.50p | Automatic Execution |
08:26:05 - 15-Jan-26 |
| Sell* | 149 | 319.50p | Automatic Execution |
08:26:05 - 15-Jan-26 |
| Sell* | 479 | 320.50p | Automatic Execution |
08:19:08 - 15-Jan-26 |
| Sell* | 136 | 320.50p | Automatic Execution |
08:19:08 - 15-Jan-26 |
| Sell* | 533 | 320.50p | Automatic Execution |
08:09:56 - 15-Jan-26 |
| Sell* | 207 | 320.24p | Ordinary |
08:09:09 - 15-Jan-26 |
Genuit Group (GEN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 12th Jan 2026 5:41 pm | RNS | Holding(s) in Company |
| 31st Dec 2025 10:00 am | RNS | Total Voting Rights |
| 31st Dec 2025 10:00 am | RNS | Total Voting Rights |
| 23rd Dec 2025 9:08 am | RNS | Holding(s) in Company |
| 23rd Dec 2025 9:08 am | RNS | Holding(s) in Company |
| 23rd Dec 2025 9:06 am | RNS | Holding(s) in Company |
| 23rd Dec 2025 9:06 am | RNS | Holding(s) in Company |
| 16th Dec 2025 2:03 pm | RNS | Holding(s) in Company |
| 16th Dec 2025 2:01 pm | RNS | Holding(s) in Company |
| 12th Dec 2025 3:41 pm | RNS | Director/PDMR Shareholding |